VLDMVery Large Dimension Manager
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
To address this issue, a cardiovascular inflammation reduction trial (CIRT: ClinicalTrials.gov.ID# NCT01594333) has begun at the Brigham and Women's Hospital and the National Heart, Lung, and Blood Institute (NHLBI) that proposes the use of very-low-dose-methotrexate (VLDM, 10 mg weekly) on 7,000 patients with stable coronary artery disease and persistent elevations of high-sensitivity C-reactive protein (Hs-CRP).